MDRNA loses $12.3M in Q4 - Puget Sound Business Journal (Seattle):

tenamup.wordpress.com
million, or a loss of 39 centas per share, which compares with a net lossof $12 or a loss of 47 centa per share a year earlier. Revenues at the Bothel biotech (NASDAQ: MRNA) fell to $147,000 from $6.1 millionm in 2007. For fiscal 2008, the company reportes a loss of $59.2 million, or a loss of $2.01 per compared with a loss of $52.3 million, or a loss of $2.19 per share a year earlier. Revenues fell to $2.6 million from $18. 1 million in fiscal 2007. No majot analysts cover the company. A one-time $8.3 millionh restructuring charge affectedfiscal 2008. . Revenueas were less in fiscal 2008 dueto (NYSE: PG) pullinbg out of a partnership deal in 2007.
Sincre then the company has refocused itself on RNAinterferencew research. Company officials said they ended fiscak 2008with $3.4 million in cash and cash equivalents, compared with $41.65 million at the end of 2007. They said becausre of the company’s low cash position, they expect to receive a “goingb concern” opinion from their accountants, whic will be filed with the company’s annuao 10-K report for the fiscal Shares in MDRNA fell more than 16 percent inTuesdagy trading, falling 7 centse to close at 36